Table 1 Demographic characteristics of primary LC patients with or without t-AML
Variables, No. (%) | With t-AML (N = 104) | Without t-AML (N = 158,541) | P |
|---|---|---|---|
Sex | 0.087 | ||
Male | 52 (50) | 92,390 (58.3) | |
Female | 52 (50) | 66,151 (41.7) | |
Race | 0.999 | ||
White | 86 (82.7) | 130,695 (82.4) | |
Black | 11 (10.6) | 16,891 (10.7) | |
Other | 7 (6.7) | 10,824 (6.8) | |
Age of LC diagnosis, median (range) | 62.5 (41–82) | 64 (10–100) | 0.332 |
< 65 years | 58 (55.8) | 80,876 (51.0) | |
≥ 65 years | 46 (44.2) | 77,665 (49.0) | |
Period of diagnosis | 0.131 | ||
1975–1984 | 7 (6.7) | 22,500 (14.2) | |
1985–1994 | 12 (11.5) | 33,044 (20.8) | |
1995–2004 | 29 (27.9) | 45,654 (28.8) | |
2005–2015 | 56 (53.8) | 57,342 (36.2) | |
Surgical treatment | 0.006 | ||
Yes | 22 (21.2) | 19,395 (12.2) | |
No | 82 (78.8) | 139,146 (87.8) | |
Radiation treatment | 0.001 | ||
Yes | 78 (75.0) | 92,389 (58.3) | |
No/unknown | 26 (25.0) | 66,152 (41.7) | |
Stage | < 0.001 | ||
Localized/regional | 53 (51.0) | 41,086 (25.9) | |
Distant | 39 (37.5) | 81,744 (52.2) | |
Unknown | 12 (11.5) | 34,711 (21.9) | |
Pathologic grade | 0.659 | ||
I or II | 13 (12.5) | 16,116 (10.2) | |
III or IV | 39 (37.5) | 64,510 (40.7) | |
Unknown | 52 (50.0) | 77,915 (49.1) | |
Histologic type | 0.09 | ||
SCLC | 42 (40.4) | 51,078 (32.2) | |
NSCLC | 59 (56.7) | 96,664 (61.0) | |
Unknown | 3 (2.9) | 10,799 (6.8) |